S. Disponible-sur-anthierens, H. Habraken, and M. Petrovic, Points-d-information-Points-d-information/Rohypnol- flunitrazepam-1-mg-Arret-de-commercialisation-Point-d-information 6 The lesser evil ? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives. Scandinavian journal of primary health care, pp.214-219, 2007.

H. Ashton, Anything for a quiet life ? Disponible sur : www.benzo.org.uk/afaql2

H. Ashton, B. Benzodiazepines-bandelow, J. Zohar, and E. Hollander, Disponible sur : www.benzo.org.uk/manual/index.htm 9 World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders -First Revision, World Journal of Biological Psychiatry, vol.9, pp.248-312, 2008.

G. Barter and M. Et-cormack, The long-term use of benzodiazepines: patients' views, accounts and experiences, Family Practice, vol.13, issue.6, pp.491-497, 1996.
DOI : 10.1093/fampra/13.6.491

S. Billioti-de-gage, B. Bégaud, and F. Bazin, Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, issue.sep27 4, pp.2012-6231
DOI : 10.1136/bmj.e6231

T. Bjørner and E. Et-laerum, Factors associated with high prescribing of benzodiazepines and minor opiates, Scandinavian Journal of Primary Health Care, vol.21, issue.2, pp.115-120, 2003.
DOI : 10.1080/02813430310001734

M. Bourin, Les benzodiazépines : de la pharmacocinétique à la dépendance

D. Burt, G. Reducing, and . Receptors, Life sciences, pp.1741-1758, 2003.

N. Chaussée, Quelles sont les motivations de prescription de benzodiazépines devant la plainte anxieuse d'une personne âgée ? Réflexion à partir d'une étude réalisée auprès de médecins généralistes de Haute- Garonne et d'internes de médecine générale en Midi-Pyrénées

Y. Clement and G. Et-chapouthier, Biological bases of anxiety, Neuroscience & Biobehavioral Reviews, vol.22, issue.5, 1998.
DOI : 10.1016/S0149-7634(97)00058-4

J. Cockburn and S. Et-pit, Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations??a questionnaire study, BMJ, vol.315, issue.7107, pp.7107-520, 1997.
DOI : 10.1136/bmj.315.7107.520

D. Cohen, Guide critique des médicaments de l'âme : antidépresseurs, lithium et régulateurs de l'humeur, neuroleptiques, stimulants, tranquillisants, somnifères, sevrage, 1995.

J. M. Cook, T. Biyanova, and C. Masci, Older Patient Perspectives on Long-Term Anxiolytic Benzodiazepine Use and Discontinuation: A Qualitative Study, Journal of General Internal Medicine, vol.42, issue.3, pp.1094-1100, 2007.
DOI : 10.1007/s11606-007-0205-5

J. Cosserat and A. Et-grimaldi, La relation médecin-malade, 2004.

F. Crichton and K. Et-petrie, Accentuate the positive: Counteracting psychogenic responses to media health messages in the age of the Internet, Journal of Psychosomatic Research, vol.79, issue.3, pp.185-189, 2015.
DOI : 10.1016/j.jpsychores.2015.04.014

R. Cumming and D. Et-le-couteur, Benzodiazepines and Risk of Hip Fractures in Older People, CNS Drugs, vol.281, issue.11, pp.825-837, 2003.
DOI : 10.2165/00023210-200317110-00004

R. Davidson, Anxiety and affective style: role of prefrontal cortex and amygdala, Biological Psychiatry, vol.51, issue.1, pp.68-80, 2002.
DOI : 10.1016/S0006-3223(01)01328-2

. Conférence-débat, Marché des médicaments psychotropes: construction historique d'une dérive, 2008.

P. Dorosz, Guide pratique des médicaments, p.32

J. Doucet and M. Et-kerkhofs, Exploration du sommeil chez l'adulte et l'adolescent. EMC -Psychiatrie, pp.176-187, 2004.
DOI : 10.1016/s0246-1072(04)38433-6

F. Ferreri, C. Agbokou, and P. Nuss, Clinique des ??tats d??pressifs, EMC - Psychiatrie, vol.3, issue.2, pp.1-19, 2006.
DOI : 10.1016/S0246-1072(06)44522-3

T. Freedom, Pharmacologic treatment of insomnia. Disease-a-month: DM, pp.345-352, 2011.

A. Froment, Pour une rencontre soignante, 2001.

T. Furukawa, Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term, Evidence-Based Mental Health, vol.7, issue.2, p.46, 2004.
DOI : 10.1136/ebmh.7.2.46

M. Godfryd, Les maladies mentales de l'adulte. Que sais-je? Presses universitaires de France, 2011.

P. Graziani, Soigner les addictions par les TCC, 2013.

A. L. Hautemulle, utilisation abusive des benzodiazepines en France : causes et conséquences, Th. D : Pharmacie, 2005.

D. Hulst, C. Atack, J. Et-kooy, and F. , The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug discovery today, pp.17-18, 2009.

K. Jones, S. Nielsen, and R. Bruno, Benzodiazepines -Their role in aggression and why GPs should prescribe with caution, Australian family physician, vol.40, issue.11, pp.862-865, 2011.

D. Kervasdoué, J. Et-lepoutre, and R. , La santé mentale des Français, Odile Jacob, 2002.

E. Lado, M. Vacariza, and C. Fernández-gonzález, Influence exerted on drug prescribing by patients??? attitudes and expectations and by doctors??? perception of such expectations: a cohort and nested case-control study, Journal of Evaluation in Clinical Practice, vol.48, issue.3, pp.453-459, 2008.
DOI : 10.1046/j.1369-6513.2002.00187.x

. Anthropologie-de-la-maladie, Etude ethnologique des systèmes de représentations étiologiques et thérapeutiques dans la société occidentale contemporaine, 1992.

N. Lechevallier-michel, C. Berr, and A. Et-fourrier-réglat, Incidence and Characteristics of Benzodiazepine Use in an Elderly Cohort: The EVA Study, Th??rapie, vol.60, issue.6, pp.561-566, 2005.
DOI : 10.2515/therapie:2005078

P. Lemoine, Tranquillisants, hypnotiques, vivre avec ou sans ? : risques et bénéfices de la sérénité chimique. Flammarion médecine-sciences, 1999.

P. Lemoine and F. Lupu, Quiproquos sur ordonnance, 2006.
URL : https://hal.archives-ouvertes.fr/halshs-00394266

M. Linden, T. Bär, and B. Et-geiselmann, Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions, Psychological Medicine, vol.28, issue.3, pp.721-729, 1998.
DOI : 10.1017/S0033291798006734

P. Little, M. Dorward, and G. Warner, Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study, BMJ, vol.328, issue.7437, pp.7437-444, 2004.
DOI : 10.1136/bmj.38013.644086.7C

S. Marriott and P. Et-tyrer, Benzodiazepine Dependence, Drug Safety, vol.9, issue.2, pp.93-103, 1993.
DOI : 10.2165/00002018-199309020-00003

D. Mesmaeker, S. Zdanowicz, N. Reynaert, and C. , Role of benzodiazepines in the treatment of anxiety disorders in 2014, Psychiatria Danubina, vol.26, issue.1, pp.23-26, 2014.

P. Midlöv, Å. Bondesson, and T. Eriksson, Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden, Family Practice, vol.23, issue.1, pp.60-64, 2006.
DOI : 10.1093/fampra/cmi105

L. Moigne, P. Et-colin, and I. , Lieux et milieux de désarroi: observation territorialisée des prescripteurs et consommateurs de psychotropes, LERS Institut du développement social, 1997.

K. Mugunthan, T. Mcguire, and P. Et-glasziou, Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis, British Journal of General Practice, vol.61, issue.590, pp.573-578, 2011.
DOI : 10.3399/bjgp11X593857

C. Nyström, Effects of long-term benzodiazepine medication. A prospective cohort study: Methodological and clinical aspects, Nordic Journal of Psychiatry, vol.21, issue.6, pp.492-497, 2005.
DOI : 10.1214/aos/1176343082

J. Parr, D. Kavanagh, and R. Young, Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis. Social science & medicine, pp.1237-1249, 2006.

A. Pélissolo, F. Maniere, and B. Boutges, Troubles anxieux et dépressifs chez 4 425 patients consommateurs de benzodiazépines au long cours en médecine générale. L'Encéphale, pp.32-38, 2007.

J. Peneff, La France malade de ses médecins. Empêcheurs de penser en rond, 2005.

P. Petit, Précis de psychopharmacologie médicale. Sauramps médical, 2011.

K. Power, A Controlled Comparison of Cognitive???Behaviour Therapy, Diazepam and Placebo in the Management of Generalized Anxiety, Behavioural Psychotherapy, vol.16, issue.01, pp.1-14, 1989.
DOI : 10.1136/bmj.288.6424.1135

B. Primack and . Review, Review: Minimal interventions (e.g., a letter) reduce long-term benzodiazepine use in primary care, Annals of Internal Medicine, vol.156, issue.4, pp.2-08, 2012.
DOI : 10.7326/0003-4819-156-4-201202210-02008

D. Ramchandani, The librium story

C. Rat, G. Penhouet, and A. Gaultier, Did the new French pay-for-performance system modify benzodiazepine prescribing practices? BMC health services research, p.301, 2014.

. Roche-(-Épouse-le-geay-)-m-c, Prescription prolongée de benzodiazépine en médecine générale: entretien auprès de dix femmes, Th. D: Médecine : Angers, 2005.

S. Rosman, Les pratiques de prescription des antibiotiques en médecine générale en France et aux Pays-Bas. Revue sociologie santé, pp.81-99, 2009.

S. Rosman, Les pratiques de prescription des médecins généralistes Une étude sociologique comparative entre la France et les Pays-Bas. Singuliers généralistes. Sociologie de la médecine générale, pp.117-149

M. Sim, E. Khong, and T. Et-wain, The prescribing dilemma of benzodiazepines, Australian family physician, vol.36, issue.11, pp.923-926, 2007.

B. Smink, A. Egberts, and K. Lusthof, The Relationship between Benzodiazepine Use and Traffic Accidents, CNS Drugs, vol.70, issue.Suppl. 2, pp.639-653, 2010.
DOI : 10.2165/11533170-000000000-00000

. Spf-santé-publique, Sécurité de la Chaîne Alimentaire et Environnement Manuel d'aide aux médecins généralistes. Campagne fédérale pour l'usage rationnel des benzodiazépines Disponible sur: www.health.fgov.be/benzo 85, Stahl S. Psychopharmacologie essentielle : bases neuroscientifiques et applications pratiques. Médecine sciences publications, 2005.

C. Vicens, F. Fiol, and J. Llobera, Withdrawal from long-term benzodiazepine use: randomised trial in family practice, The British Journal of General Practice, vol.56, pp.533-958, 2006.

R. Voshaar, J. Couvée, and A. Van-balkom, Strategies for discontinuing long-term benzodiazepine use: Meta-analysis, The British Journal of Psychiatry, vol.189, issue.3, pp.213-220, 2006.
DOI : 10.1192/bjp.189.3.213

R. Voshaar, W. Gorgels, and A. Mol, Predictors of Long-Term Benzodiazepine Abstinence in Participants of a Randomized Controlled Benzodiazepine Withdrawal Program, The Canadian Journal of Psychiatry, vol.8, issue.7, pp.445-452, 2006.
DOI : 10.1177/070674370605100706

I. Willems, W. Gorgels, and R. Voshaar, Tolerance to benzodiazepines among long-term users in primary care. Family practice, pp.404-410, 2013.

R. Wilson, J. Hatcher, and S. Barton, The influence of practice characteristics on the prescribing of benzodiazepines and appetite suppressant drugs, Pharmacoepidemiology and Drug Safety, vol.7, issue.4, pp.243-251, 1998.
DOI : 10.1002/(SICI)1099-1557(199807/08)7:4<243::AID-PDS338>3.0.CO;2-K

S. Zandstra, Long-term benzodiazepine users in family practice: differences from short-term users in mental health, coping behaviour and psychological characteristics, Family Practice, vol.21, issue.3, pp.266-269, 2004.
DOI : 10.1093/fampra/cmh309

E. Zarifian, Le prix du bien-être : Psychotropes et société, Odile Jacob, 1996.

. Le-système-de-santé-en-france, Disponible sur : http://www.gipspsi.org/content/download, Livre_gipspsi_Livre_sante_2013_web.pdf 99, 10084.

R. Médecins-traitants, Disponible sur : http://www.ameli.fr/professionnels-de-sante/medecins/votreconvention/remuneration-sur-objectifs-de-sante-publique/rosp-medecins-traitants/les-indicateurs-dorganisation-du-cabinet_loire-atlantique

. Le-bilan-social-officiel-de-la-crise-Économique, . Le-huffington, and . Post, Disponible sur : http://www.huffingtonpost.fr, 2014.